Vyas Purvi, Thakar A B, Baghel M S, Sisodia Arvind, Deole Yogesh
Kshara Sutra Vaidya -Class 1, Smt.Maniben M.A.H. Government Ayurvedic Hospital, Asarava, Ahmedabad, India.
Ayu. 2010 Oct;31(4):417-23. doi: 10.4103/0974-8520.82029.
Cancer is the most dreadful disease affecting mankind. The available treatments such as chemotherapy and radiotherapy have cytotoxic effects, which are hazardous to the normal cells of the patient, causing many unnecessary effects. This further leads to complications of the therapy, impaired health, and deterioration of quality of life, resulting in mandatory stoppage of the treatment. In the present study, the efficacy of an Ayurvedic formulation, Rasayana Avaleha, has been evaluated as an adjuvant medication to modern radiotherapy and chemotherapy. A total of 36 cancer patients were registered in this trial and were divided into two groups, group A and group B. In group A, the patients were treated with radiotherapy and chemotherapy along with adjuvant Rasayana Avaleha (RT + CT + RA), while in group B only radiotherapy and chemotherapy (RT + CT) were given, as the control group. After assessing the results, it was observed that Rasayana Avaleha gave better results in controlling the adverse effect of chemotherapy and radiotherapy in comparison with the control group. Therefore, Rasayana Avaleha has proved to be an effective adjuvant therapy in protecting patients from the adverse effects of chemotherapy and radiotherapy.
癌症是影响人类的最可怕疾病。现有的治疗方法，如化疗和放疗，具有细胞毒性作用，对患者的正常细胞有害，会引发许多不必要的影响。这进一步导致治疗并发症、健康受损以及生活质量下降，从而导致治疗不得不停止。在本研究中，一种阿育吠陀制剂——Rasayana Avaleha，已被评估作为现代放疗和化疗的辅助药物。本试验共登记了36名癌症患者，并将其分为两组，A组和B组。A组患者接受放疗、化疗以及辅助药物Rasayana Avaleha（RT + CT + RA）治疗，而B组仅接受放疗和化疗（RT + CT）作为对照组。评估结果后发现，与对照组相比，Rasayana Avaleha在控制化疗和放疗的不良反应方面效果更好。因此，Rasayana Avaleha已被证明是一种有效的辅助疗法，可保护患者免受化疗和放疗的不良反应。
